You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
天壇生物(600161.SH):蘭州血制擬建血液製品生產車間 設計產能投漿量1200噸/年
格隆匯 10-28 16:44

格隆匯 10 月 28日丨天壇生物(600161.SH)公佈,公司所屬蘭州蘭生血液製品有限公司(“蘭州血制)擬在蘭州市國家高新技術開發區中生科技健康產業園區內建設血液製品生產車間,設計產能投漿量1200/,產品包括人血白蛋白、靜注人免疫球蛋白和人凝血酶原復合物等。同時配套建設質檢車間、高架倉庫、污水處理站、動力中心、危化品庫、乙醇回收站、罐區及預留生產區域。

項目投資總金額為128657.33萬元,其中,固定資產建設投資111415.72萬元,利舊設備2137.40萬元,鋪底流動資金15104.21萬元。金來源為自有資金以及公司非公開發行A股股票募集資金,該項目擬使用公司非公開發行A股股票募集資金投入金額為9.6億元。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account